Excessive sweating in several separate areas: sweating across several limited to certain areas regions

When another cause may need to be checked

• True generalized sweating — sweating that involves the whole body rather than discrete limited to certain areas regions — is not excessive sweating in several separate areas. Generalized sweating raises secondary-cause concern and is addressed on the all-over / new-onset when to see a clinician page.
• Sweating in many regions that began suddenly in adulthood, is accompanied by whole-body symptoms, or includes night sweats deserves in-person evaluation rather than treating the sweating itself.

Common patterns and symptoms

• • On both sides of the body sweating in two or more limited to certain areas regions (e.g., underarms + hands)
• • Symmetric pattern, present since adolescence or early adulthood
• • Sweating stops during sleep across all involved regions
• • Treatment burden of region-specific options multiplied across sites

Why oral options enter the usual order of options earlier

When sweating spans several limited to certain areas regions, the treatment economics change. Topical and in-office procedures are typically region-specific: Qbrexza for one underarm cycle, separate iontophoresis sessions for hands and feet, separate Botox treatments per site. Pills that reduce sweating — glycopyrrolate and oxybutynin — act systemically and address multi-region sweating with one daily medication. The tradeoff is the sweat-reducing medicine side-effect profile: dry mouth, urinary retention, blurred vision, constipation, and cognitive effects in older adults.

When to keep the regional approach

In several separate areas disease can still be approached region-by-region when the side-effect burden of pills that reduce sweating is unacceptable or contraindicated. The typical pattern is layered: aluminum chloride or Qbrexza/Sofdra for underarm, iontophoresis for palms and feet, and onabotulinumtoxinA injections for the most-bothersome single region. This avoids whole-body exposure at the cost of more treatment burden and more provider visits.

What this is not

Excessive sweating in several separate areas is not generalized sweating. The hallmark of common area-specific patterns — on both sides of the body, symmetric, started early, stops during sleep — still applies when multiple regions are involved. Generalized sweating, sweating mainly at night, or sweating with whole-body symptoms is addressed on the all-over / new-onset page and typically needs in-person evaluation.

Reading paths

Each affected region has its own treatment page with the region-specific order of options. The /treatments/glycopyrrolate-oral and /treatments/oxybutynin pages cover the whole-body options that in several separate areas patients most often consider. The comparison page on pills that reduce sweating walks through the practical differences between glycopyrrolate and oxybutynin.

Treatment options for this type of sweating

Frequently asked

Should I take oral medication if I have in several separate areas sweating?

Pills that reduce sweating are a stronger option for in several separate areas disease because they address several regions with one medication. Whether they are the right next step depends on severity (HDSS in each region), tolerance of side effects such as dry mouth, constipation, blurred vision, and trouble urinating, and whether topical or in-office procedures have been tried. A clinician's risk-benefit assessment is part of the decision.

Can I do iontophoresis and use Qbrexza at the same time?

There is no specific reason a treatment may not be safe to combining underarm Qbrexza with hand or foot iontophoresis — they act on different regions through different mechanisms. The total daily treatment burden is the main consideration. People with in several separate areas disease often layer region-specific approaches before considering whole-body medication.

Reading paths

• Check your severity with the HDSS calculator →
• All hyperhidrosis treatments →
• Compare treatments →
• How Ecrina checks health claims →